NCT01595750 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Status UNKNOWN Phase PHASE4
NCT01592656 Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients Status TERMINATED Phase PHASE2
NCT01587079 Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2
NCT01582958 The Effect of OMT on Patients With COPD: Correlating Pulmonary Function Tests With Biochemical Alterations Status COMPLETED Phase NA
NCT01580423 The Role of Substance P on Perception of Breathlessness During Resistive Load Breathing Status COMPLETED Phase NA
NCT01577329 Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase NA
NCT01576068 Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry Status UNKNOWN Phase EARLY_PHASE1
NCT01572792 Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE3
NCT01566773 PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD Status COMPLETED Phase PHASE2
NCT01561625 Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase NA
NCT01560741 Telemedicine and Ventilator Titration in Chronic Respiratory Patients Initiating Non-invasive Ventilation Status UNKNOWN Phase PHASE1
NCT01559051 Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease Status WITHDRAWN Phase PHASE1/PHASE2
NCT01556139 Effectiveness of Respiratory Muscle Training by Spirotiger in Chronic Patients Status COMPLETED Phase NA
NCT01555138 Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) Status COMPLETED Phase PHASE4
NCT01554774 Non-invasive Assessment of Pulmonary Vascular Resistance in Elderly Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT01554488 Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease Status TERMINATED Phase PHASE4
NCT01551316 Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE1